UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trans-ungual Delivery of AR-12, a Novel Antifungal Drug

AAPS PharmSciTech, 2017-10, Vol.18 (7), p.2702-2705

2017

Volltextzugriff (PDF)

473 Evaluation of the Relation Specific PR Biomarkers to the Preclinical Activity of Onapristone

European journal of cancer (1990), 2012-11, Vol.48, p.146-147

2012

Volltextzugriff (PDF)

431 Real-time pharmacokinetic (PK) results from an ongoing randomized, parallel-dose phase 1 study of onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers

European journal of cancer (1990), 2014-11, Vol.50, p.142-142

2014

Volltextzugriff (PDF)

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer

Journal of clinical oncology, 1994-04, Vol.12 (4), p.683-688

1994

Volltextzugriff (PDF)

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2272-2277

1995

Volltextzugriff (PDF)

Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus

Gynecologic oncology, 2015-09, Vol.138 (3), p.663-667

2015

Volltextzugriff (PDF)

Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors

Journal of clinical oncology, 1994-01, Vol.12 (1), p.184-193

1994

Volltextzugriff (PDF)

Abstract P6-05-13: Tumor and cellular distribution of activated forms of ER and PR in breast cancers

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P6-P6-05-13

2013

Volltextzugriff (PDF)

Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort

ESMO open, 2016, Vol.1 (4), p.e000072-e000072, Article e000072

2016

Volltextzugriff (PDF)

Phase II Trial of Low Dose γ-Interferon in Metastatic Renal Cell Carcinoma

The Journal of urology, 1994-09, Vol.152 (3), p.841-845

1994

Volltextzugriff (PDF)

Increased incidence of hypersensitivity to iodine‐containing radiographic contrast media after interleukin‐2 administration

Cancer, 1990-04, Vol.65 (7), p.1521-1524

1990

Volltextzugriff (PDF)

Splenic versus hepatic artery infusion of interleukin-2 in patients with liver metastases

Journal of clinical oncology, 1990-02, Vol.8 (2), p.319-324

1990

Volltextzugriff (PDF)

Combination recombinant interleukin-2, recombinant interferon-α, and 5-fluorouracil for treatment of metastatic renal cell carcinoma

American journal of clinical oncology, 1995-08, Vol.18 (4), p.358-362

1995

Volltextzugriff (PDF)

Indium-111-Labeled B72.3 Monoclonal Antibody in the Detection and Staging of Breast Cancer: A Phase I Study

The Journal of nuclear medicine (1978), 1991-07, Vol.32 (7), p.1326-1332

1991

Volltextzugriff (PDF)

Regression of hepatic metastases from gastrointestinal leiomyosarcoma after hepatic arterial chemoembolization

Cancer, 1991-07, Vol.68 (2), p.321-323

1991

Volltextzugriff (PDF)

Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapy

Cancer Immunology Immunotherapy, 1991-07, Vol.33 (4), p.238-246

1991

Volltextzugriff (PDF)

Identification of the activated form of the estrogen receptor (ER) in breast cancer (BC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e11535-e11535

2013

Volltextzugriff (PDF)

Clinical and pathologic correlation of the activated form of the estrogen receptor (ER) in breast cancer (BC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.592-592

2013

Volltextzugriff (PDF)

Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases

Cancer, 1992-01, Vol.69 (2), p.557-561

1992

Volltextzugriff (PDF)

Independent characterization by duel staining of progesterone receptor (PR) and estrogen receptor (ER) in breast cancer (BC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.596-596

2013

Volltextzugriff (PDF)

Identification of the activated form of the progesterone receptor (PR) in breast cancer (BC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.593-593

2013

Volltextzugriff (PDF)

Severe, symptomatic, dose‐limiting hypophosphatemia induced by hepatic arterial infusion of recombinant tumor necrosis factor in patients with liver metastases

Cancer, 1991-05, Vol.67 (10), p.2459-2461

1991

Volltextzugriff (PDF)

5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen

Anticancer research, 1994-05, Vol.14 (3B), p.1265

1994

Volltextzugriff (PDF)

Determination of the activated form of the progesterone receptor (PR) in endometrial cancer (EC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.5602-5602

2013

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

Humans
(29)
Science & Technology
(26)
Life Sciences & Biomedicine
(24)
Female
(19)
Oncology
(18)
Male
(17)
Middle Aged
(17)
Aged
(15)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Adult
(14)
Pharmacology. Drug Treatments
(13)
Antineoplastic Agents
(10)
Interleukin-2 - Therapeutic Use
(6)
Melanoma - Therapy
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Combined Treatments
(5)
Immunotherapy
(5)
Liver Neoplasms - Secondary
(5)
Recombinant Proteins
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trans-ungual Delivery of AR-12, a Novel Antifungal Drug

473 Evaluation of the Relation Specific PR Biomarkers to the Preclinical Activity of Onapristone

Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) alone or in combination with abiraterone (AA) in patients (pts) with castration-resistant prostate cancer (CRPC) incorporating plasma DNA analysis to define androgen receptor (AR) status

431 Real-time pharmacokinetic (PK) results from an ongoing randomized, parallel-dose phase 1 study of onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial

Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus

Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors

Abstract P6-05-13: Tumor and cellular distribution of activated forms of ER and PR in breast cancers

Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort

Phase II Trial of Low Dose γ-Interferon in Metastatic Renal Cell Carcinoma

Increased incidence of hypersensitivity to iodine‐containing radiographic contrast media after interleukin‐2 administration

Splenic versus hepatic artery infusion of interleukin-2 in patients with liver metastases

Combination recombinant interleukin-2, recombinant interferon-α, and 5-fluorouracil for treatment of metastatic renal cell carcinoma

Indium-111-Labeled B72.3 Monoclonal Antibody in the Detection and Staging of Breast Cancer: A Phase I Study

Regression of hepatic metastases from gastrointestinal leiomyosarcoma after hepatic arterial chemoembolization

Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapy

Identification of the activated form of the estrogen receptor (ER) in breast cancer (BC)

Clinical and pathologic correlation of the activated form of the estrogen receptor (ER) in breast cancer (BC)

Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases

Independent characterization by duel staining of progesterone receptor (PR) and estrogen receptor (ER) in breast cancer (BC)

Identification of the activated form of the progesterone receptor (PR) in breast cancer (BC)

Severe, symptomatic, dose‐limiting hypophosphatemia induced by hepatic arterial infusion of recombinant tumor necrosis factor in patients with liver metastases

5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen

Determination of the activated form of the progesterone receptor (PR) in endometrial cancer (EC)

Suchergebnisse filtern